TMCnet News
Global Melanoma Diagnostics & Therapeutics Market Worth USD 5,450 Million by 2020 - Analysis, Technologies & Forecasts Report 2015-2020 - Key Vendors: Abbott Diagnostics, Roche, Eli Lilly - Research and MarketsResearch and Markets has announced the addition of the "Global Melanoma Diagnostics and Therapeutics Market - Segmented by type of cancer and Geography (2015-2020)" report to their offering. The global melanoma diagnostics and therapeutics market was valued at USD 2,662 million in 2015 and is expected to reach USD 5,450 million by 2020. Melanoma is one of the serious types of skin cancer that develops from pigment-containing cells called melanocytes. The market for melanoma diagnostics and therapeutics is increasing at a significant rate due to an increase in the prevalence of melanoma and improvement in healthcare facilities. In addition, government initiatives and technical advancements boost the market growth. USA has the biggest market size, due to its large population, and higher prevalence and treatment rates. North America dominates the melanoma market. Europe also shows potential for higher market epansion because of the treatment rates and market infiltration of premium drugs. However, Japan, China and India in the Asia-Pacific region are expected to be the fastest-growing melanoma diagnostics and therapeutics markets. Drivers:
Restraints:
Companies Mentioned:
Report Structure: 1. Introduction 2. Executive Summary 3. Market Overview 4. Porters Five Force Analysis 5. Market Segmentation 6. Competitive Landscape 7. Company Profiles 8. Appendix For more information visit http://www.researchandmarkets.com/research/jl5dts/global_melanoma View source version on businesswire.com: http://www.businesswire.com/news/home/20160725005678/en/ |
